Horst G. Zerbe
Net Worth

Last updated:

What is Horst G. Zerbe net worth?

The estimated net worth of Dr. Horst G. Zerbe is at least $4,934,355 as of 30 Sep 2022. He owns shares worth $70,813 as insider, has earned $289,292 from insider trading and has received compensation worth at least $4,574,250 in IntelGenx Technologies Corp..

What is the salary of Horst G. Zerbe?

Dr. Horst G. Zerbe salary is $240,750 per year as Chairman, Chief Executive Officer & Chairman of Scientific Advisory Board in IntelGenx Technologies Corp..

How old is Horst G. Zerbe?

Dr. Horst G. Zerbe is 78 years old, born in 1947.

What stocks does Horst G. Zerbe currently own?

As insider, Dr. Horst G. Zerbe owns shares in one company:

Company Title Shares Price per share Total value
IntelGenx Technologies Corp. (IGXT) Chairman, Chief Executive Officer & Chairman of Scientific Advisory Board 354,064 $0.2 $70,813

What does IntelGenx Technologies Corp. do?

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

IGXT logo
IGXT
IntelGenx Technologies Corp.
$0.2

Horst G. Zerbe insider trading

IntelGenx Technologies Corp.

Dr. Horst G. Zerbe has made 11 insider trades between 2006-2022, according to the Form 4 filled with the SEC. Most recently he purchased 5,000 units of IGXT stock worth $640 on 30 Sep 2022.

The largest trade he's ever made was exercising 225,000 units of IGXT stock on 9 Nov 2006. As of 30 Sep 2022 he still owns at least 354,064 units of IGXT stock.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock, 0.00001 p.V 5,000 $0.13 $640
Purchase
Common Stock, 0.00001 p.V 14,000 $0.12 $1,736
Sale
Common Stock ($0.00001 par value) 36,900 $0.5 $18,450
Sale
Common Stock (par value 0.00001) 10,000 $0.66 $6,550
Sale
Common Stock (par value 0.00001) 5,175 $0.66 $3,416
Sale
Common Stock (par value 0.00001) 10,000 $0.66 $6,550
Sale
Common Stock (par value 0.00001) 14,825 $0.65 $9,666
Sale
Common Stock (par value 0.00001) 2,500 $0.69 $1,713
Sale
Common Stock (par value 0.00001) 14,950 $0.68 $10,166
Sale
Common Stock (par value 0.00001) 2,550 $0.69 $1,759
Sale
Common Stock (par value $0.00001) 41,000 $0.93 $38,253
Sale
Common Stock (par value $0.00001) 9,000 $0.93 $8,370
Sale
Common Stock (par value $0.00001) 200,000 $0.92 $184,400
Option
Common Shares ($0.00001 par value) 225,000 $0.41 $92,250
Option
Options (rights to buy) 225,000 $0.41 $92,250
Option
Common Stock ($0.0001 par value) 225,000 $0.41 $92,250
Option
Option (Right to buy) 225,000 $0.41 $92,250

IntelGenx Technologies Corp. key executives

IntelGenx Technologies Corp. executives and other stock owners filed with the SEC:

  • Dr. Dana Matzen (47) Vice President of Bus. & Corporation Devel. of IntelGenx Corp
  • Dr. Horst G. Zerbe (78) Chairman, Chief Executive Officer & Chairman of Scientific Advisory Board
  • Mr. André Godin C.A., CPA, CPA, CA (61) Pres & Chief Financial Officer
  • Ms. Nadine Paiement (48) Vice-Chair of Scientific Advisory Board and Vice President of R&D - IntelGenx Corp